BLS Pharmaceuticals Limited (ASX:BLS)
Australia · Delayed Price · Currency is AUD 1.040
+0.025 (2.46%)
Oct 13, 2026, 4:10 PM AEST
BLS Pharmaceuticals Market Cap
BLS Pharmaceuticals has a market cap or net worth of 239.52 million as of October 12, 2026. It is the 22,079th most valuable company in the world and the 444th biggest in Australia. Its market cap has increased by 198.06% in one year.
Market Cap
239.52M
Enterprise Value
234.66M
Revenue
73.91M
Global Rank
Country Rank
#444 Australia
PE Ratio
15.15
ChartMarket Cap Chart
Since April 10, 2012, BLS Pharmaceuticals's market cap has increased from 31.38M to 239.52M, an increase of 663.28%. That is a compound annual growth rate of 15.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 239.52M | 156.26% |
| Dec 31, 2025 | 93.47M | 68.93% |
| Dec 31, 2024 | 55.33M | 164.50% |
| Dec 29, 2023 | 20.92M | 30.94% |
| Dec 29, 2022 | 15.98M | -13.94% |
| Dec 31, 2021 | 18.56M | 141.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Starpharma Holdings | 398.18M |
| Clinuvel Pharmaceuticals | 395.35M |
| Tetratherix | 331.61M |
| Racura Oncology | 324.49M |
| Orthocell | 183.18M |
| Actinogen Medical | 180.85M |
| Paradigm Biopharmaceuticals | 146.80M |
| Dimerix | 132.09M |